Close log in window
Closer relationships with patients and a better understanding of what matters to them will show the way improving their experience of trials
There is a golden opportunity to deliver clinical trial innovation post-pandemic given healthcare’s appetite for new approaches, such as v...
The impacts of 2020 on trials are causing pharma to consider a new direction for trial sites, taking them closer to the patient
Broader and deeper outreach, along with RWE, are some of the methods pharma is using to widen trials participation